Mortality associated with benzodiazepines and benzodiazepine-related drugs among community-dwelling older people in Finland: A population-based retrospective cohort study

Canadian Journal of Psychiatry

Volumn 56, Issue 6, 2011, Pages 377-381

  Gisev, Natasa ^a   Hartikainen, Sirpa ^b,c   Chen, Timothy F ^a   Korhonen, Mikko ^c   Bell, J Simon ^a,b,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c Leppavirta Health Centre   (Finland)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Aged; Benzodiazepines; Hypnotics and sedatives; Mortality; Pharmacoepidemiology

Indexed keywords

BENZODIAZEPINE; DIAZEPAM; NEUROLEPTIC AGENT; OXAZEPAM; TEMAZEPAM; ZOLPIDEM; ZOPICLONE;

AGED; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; DRUG FATALITY; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; REIMBURSEMENT; RETROSPECTIVE STUDY;

EID: 79960458504     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371105600609     Document Type: Article

References (19)

1. Hogan DB, Maxwell CJ, Fung TS, et al. Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian Study of Health and Aging. Can J Clin Pharmacol. 2003;10:72-77. (Pubitemid 37028597)
2. Hartikainen S, Klaukka T. Use of psychotropics is high among very old people. Eur J Clin Pharmacol. 2004;59:849-850. (Pubitemid 38221664)
3. Beland SG, Preville M, Dubois MF, et al. Benzodiazepine use and quality of sleep in the community-dwelling elderly population. Aging Ment Health. 2010;14:843-850.
4. Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf. 1999;21:101-122. (Pubitemid 29389171)
5. Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs. 2003;17:825-837. (Pubitemid 37082985)
6. Pariente A, Dartigues J-F, Benichou J, et al. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging. 2008;25:61-70.
7. van Vliet P, van der Mast RC, van den Broek M, et al. Use of benzodiazepines, depressive symptoms and cognitive function in old age. Int J Geriatr Psychiatry. 2009;24:500-508.
8. el-Guebaly N, Sareen J, Stein MB. Are there guidelines for the responsible prescription of benzodiazepines? Can J Psychiatry. 2010;55:709-714.
9. Charlson F, Degenhardt L, McLaren J, et al. A systematic review of research examining benzodiazepine-related mortality. Pharmacoepidemiol Drug Saf. 2009;18:93-103.
10. Belleville G. Mortality hazard associated with anxiolytic and hypnotic drug use in the National Population Health Survey. Can J Psychiatry. 2010;55:558-567.
11. Bell JS, Lavikainen P, Korhonen M, et al. Benzodiazepine discontinuation among community-dwelling older people: a population-based cohort study. Eur J Clin Pharmacol. 2011;67;105-106.
12. Furu K, Wettermark B, Andersen M, et al. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010;106:86-94.
13. Haukka J, Suvisaari J, Tuulio-Henriksson A, et al. High concordance between self-reported medication and official prescription database information. Eur J Clin Pharmacol. 2007;63:1069-1074. (Pubitemid 47561801)
14. Rikala M, Hartikainen S, Sulkava R, et al. Validity of the Finnish Prescription Register for measuring psychotropic drug exposures among elderly Finns: a population-based intervention study. Drugs Aging. 2010;27:337-349.
15. Social Insurance Institution of Finland. Lääkkeet ja lääkekorvaukset. Helsinki (FI): Kela; 2011 [cited 2010 Nov 25]. Available from: http://www.kela.fi/in/internet/suomi.nsf/NET/160204153342EE? OpenDocument.
16. World Health Organization Collaborating Centre for Drugs Statistics Methodology. The Anatomical Therapeutic Chemical Classification System. WHO Collaborating Centre for Drugs Statistics Methodology. Norweigan Institute of Public Health. Geneva (CH): WHO; 2010 [cited 2010 Nov 25]. Available from: http://www.whocc.no/atcddd
17. Hausken AM, Skurtveit S, Tverdal A. Use of anxiolytic or hypnotic drugs and total mortality in a general middle-aged population. Pharmacoepidemiol Drug Saf. 2007;16:913-918. (Pubitemid 47333543)
18. Lau HS, de Boer A, Beuning KS, et al. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol. 1997;50:619-625. (Pubitemid 27270212)
19. Gama H, Correia S, Lunet N. Questionnaire design and the recall of pharmacological treatments: a systematic review. Pharmacoepidemiol Drug Saf. 2009;18:175-187.